SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-024409
Filing Date
2017-12-01
Accepted
2017-11-30 21:34:05
Documents
2
Period of Report
2017-11-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K EX NOTE CLOSING NOV 2017 orex-8k_20171127.htm 8-K 25777
2 EX-10.1 orex-ex101_6.htm EX-10.1 57251
  Complete submission text file 0001564590-17-024409.txt   84235
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33415 | Film No.: 171232574
SIC: 2834 Pharmaceutical Preparations